Similar articles

• Phospholipids in experimental atherosclerosis.

  Altman RF, de Mendonça JM, Schaeffer GM, de Souza JR, Bandoli JG, da Silva DJ, Lopes CR. Altman RF, et al. Arzneimittelforschung. 1974 Jan;24(1):11-6. Arzneimittelforschung. 1974. PMID: 4406098 No abstract available.
• [The effect of a preparation containing unsaturated fatty acids on the course of experimental atherosclerosis in rabbits].

  Angarskaia MA, Sokolova VE, Liubartseva LA. Angarskaia MA, et al. Farmakol Toksikol. 1972 Nov-Dec;35(6):704-7. Farmakol Toksikol. 1972. PMID: 4651805 Russian. No abstract available.
• [Clinical experimental lipid metabolism studies with essential phospholipids taking into account the arteriosclerosis problem].

  Hammerl H, Pichler O, Studlar M. Hammerl H, et al. Wien Med Wochenschr. 1966 Apr 16;116(16):348-52. Wien Med Wochenschr. 1966. PMID: 5985190 German. No abstract available.
• The curious interrelation between cancer and diseases of the arteries.

  Altman RF. Altman RF. Hospital (Rio J). 1967 Oct;72(4):1027-53. Hospital (Rio J). 1967. PMID: 4897675 Review. No abstract available.
• [The possibilities of reducing serum cholesterol and lipid values in atheromatosis. (Review of the literature from 1959-1964)].

  Krýsa I. Krýsa I. Vnitr Lek. 1966 Mar;12(3):265-73. Vnitr Lek. 1966. PMID: 5327448 Review. Czech. No abstract available.